Get the Stockscreener App
3.39
74.30%
-9.80
After Hours:
3.29
-0.10
-2.95%
Cargo Therapeutics Inc stock is traded at $3.39, with a volume of 21.27M.
It is down -74.30% in the last 24 hours and down -75.36% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
See More
Previous Close:
$13.19
Open:
$3.13
24h Volume:
21.27M
Relative Volume:
37.41
Market Cap:
$156.03M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-0.9454
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
-75.51%
1M Performance:
-75.36%
6M Performance:
-79.94%
1Y Performance:
-85.20%
1-Day Range:
$3.00
$3.49
1-Week Range:
$3.00
$14.68
52-Week Range:
$3.00
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
3.39 | 156.03M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 112.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 75.06B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.45B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.75B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 28.98B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
Bay Area biotech firm guts staff, shuts trial after dangerous side effects - SFGATE
CARGO Therapeutics, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsCRGX - PR Newswire
CARGO Therapeutics stock hits 52-week low at $3.12 - MSN
Stock market news: Crown Electrokinetics -99.50%, CARGO Therapeutics -74.34% among biggest losers during mid day trading - Business Upturn
Peninsula biotech moves from IPO to chopping half its workforce in little more than a year - The Business Journals
Stock market today: Aclarion -99.69%, CARGO Therapeutics -76.31% among biggest losers in early trading - Business Upturn
Dow Jumps Over 100 Points; Tesla Earnings Miss Views - Benzinga
Cargo to drop lead CAR-T therapy, lay off staff after study setback - BioPharma Dive
This Everest Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Truist cuts Cargo Therapeutics rating, slashes PT to $7 - Investing.com India
Jefferies Downgrades CARGO Therapeutics to Hold From Buy, Price Target is $3 -January 30, 2025 at 07:31 am EST - Marketscreener.com
JPMorgan cuts Cargo Therapeutics stock rating to Underweight - Investing.com India
HC Wainwright Downgrades CARGO Therapeutics to Neutral From Buy -January 30, 2025 at 07:19 am EST - Marketscreener.com
Cargo Therapeutics stock tumbles after trial setback By Investing.com - Investing.com Canada
Cargo Therapeutics stock tumbles after trial setback - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Chardan Downgrades CARGO Therapeutics to Neutral From Buy, Withdraws $28 Price Target - Marketscreener.com
JPMorgan cuts Cargo Therapeutics stock rating to Underweight By Investing.com - Investing.com UK
Cargo Therapeutics stock rating cut by Jefferies to Hold - Investing.com
Piper Sandler cuts Cargo Therapeutics rating to neutral - MSN
CARGO Therapeutics, Inc. Announces Workforce Reduction and Strategic Shift - Defense World
Chardan cuts Cargo Therapeutics stock rating to neutral - Investing.com
CARGO halts Phase 2 study of cancer treatment - Investing.com India
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - Business Wire
Stocks to Watch : Tesla, IBM, Microsoft, Lam Research, Cargo Therapeutics -January 29, 2025 at 07:16 pm EST - Marketscreener.com
Stocks to Watch: Tesla, IBM, Microsoft, Lam Research, Cargo Therapeutics - MarketWatch
Cargo Therapeutics to Lay Off 50% of Workers, Stop Developing Blood Cancer Treatment - MarketWatch
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of - GlobeNewswire
Major Setback: CARGO's Cancer Treatment Shows Alarming Safety Issues, Forces Company Restructure - StockTitan
Fennec Pharmaceuticals (NASDAQ:FENC) versus CARGO Therapeutics (NASDAQ:CRGX) Financial Survey - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Up 6.7%What's Next? - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
CARGO Therapeutics, Inc. Enters into Sublease Agreement with Vaxcyte, Inc -July 08, 2024 at 04:18 pm EDT - Marketscreener.com
Q1 Earnings Forecast for CRGX Issued By William Blair - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Shares Up 10%What's Next? - MarketBeat
Analysts Issue Forecasts for CRGX Q1 Earnings - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Acquired by Barclays PLC - Defense World
Jane Street Group LLC Sells 51,005 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Trading Down 3.2%Here's Why - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Hits New 52-Week LowTime to Sell? - MarketBeat
CARGO Therapeutics stock hits 52-week low at $12.17 - Investing.com India
CARGO Therapeutics stock hits 52-week low at $12.17 By Investing.com - Investing.com Canada
Jane Street Group LLC Decreases Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Sold by Jane Street Group LLC - MarketBeat
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025 - GlobeNewswire
CARGO Therapeutics Advances CAR T-Cell Pipeline, Unveils Novel Allogeneic Platform With $368M Cash Position - StockTitan
When (CRGX) Moves Investors should Listen - Stock Traders Daily
CARGO Therapeutics (NASDAQ:CRGX) Shares Up 7.4%Still a Buy? - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Shares Down 4.8%Should You Sell? - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Sees Significant Growth in Short Interest - MarketBeat
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):